Publications found:
112,550
Sort by:
Interacting with KOLs: Fulfilling Current Unmet Needs
US$ 995.00
The symbiotic relationship between key opinion leaders (KOLs) and the pharmaceutical industry is dynamic and ever-changing. But while the industry knows what it wants from KOLs, what do KOLs need from...
October 2011
41 pages
PHARMASSET - 'IFN-Free Oral Option' for HCV - Not a Virgin Territory Anymore!
US$ 90.00
... ) wave to treat HCV the race to offer the first “IFN free all oral option” seems to have begun. Preliminary data from Abbott’s PhII trial ... ’11 is challenging Pharmasset (VRUS) multiprong approach. For more details, please read our report released on Oct. 24th, 2011 on VRUS titled “IFN-free Oral Option” for ...
October 2011
4 pages
Payer Agreements: Splitting the Risk
US$ 695.00
Budgets are tight. Payer funding for new products is dwindling. And for pharmaceutical companies, market access is more and more difficult to attain.Across the UK, the US, Canada, Australia and parts...
October 2011
41 pages
China Medical Information System Industry Report, 2011
US$ 1,500.00
Status quo of China medical services, including medical resource allocation, medical efficiency and main existing problems;
Policies, construction and investment of China medical information...
October 2011
52 pages
Brazil Healthcare Market Analysis
US$ 1,000.00
Backed by several factors, such as strong government support and high healthcare demand amongst others are propelling the Brazilian healthcare market to grow at a fast pace. In fact, Brazil can be cla...
October 2011
75 pages
Latino Health and Beauty Care Shopper
US$ 3,500.00
... the market for HBC products in the United States. Over the past decade, spending by Latino consumers on personal care products grew more than 40%, ... consumers of HBC products in the future. Packaged Facts The Latino Health and Beauty Care Shopper provides an in-depth analysis of the grooming and personal ...
October 2011
146 pages
Health Technology Assessment (HTA): a European perspective
US$ 995.00
The bottom line: For payers facing tough financial crunches across Europe, Health Technology Assessment (HTA) is becoming increasingly important. Not only is HTA influencing reimbursement, it is havin...
October 2011
48 pages
Boehringer Ingelheim in Consumer Health (World)
US$ 520.00
... a strong position in consumer health. While other major pharmaceutical companies, such as Bristol-Myers Squibb, are reducing their commitment to consumer products, Boehringer Ingelheim is looking to build its presence. Euromonitor International’s Boehringer Ingelheim in Consumer Health (World) Company ...
October 2011
33 pages
Boehringer Ingelheim in Consumer Health (Global)
US$ 572.00
Boehringer Ingelheim is a German-based, family-owned pharmaceutical company with a strong position in ... , are reducing their commitment to consumer products, Boehringer Ingelheim is looking to build its presence. Euromonitor International’s Boehringer Ingelheim in Consumer Health (Global) Company Profile offers ...
October 2011
33 pages
Spinal Surgery: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Spinal Surgery in US$ Million by the following Product Segments: Spinal Fusion Devices, Spinal Fixation Devices, Artificial ... Plc, SpineVision, Stryker Corporation, Synthes Inc., and Zimmer Spine Inc. Market data and analytics are derived from primary and secondary ...
October 2011
411 pages
Autoimmune Disease Therapeutics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 112 companies including many key and niche ...
October 2011
749 pages
Multiple Myeloma Therapeutics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Millennium Pharmaceuticals, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary ...
October 2011
595 pages
Wound Care Products: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Wound Care Products in US$ Million. The major Product Segments analyzed are Traditional {Wound Management Products ( ... through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 200 companies including many key and niche ...
October 2011
1027 pages
Coronary Stents: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Coronary Stents in US$ Million and Thousand Units by the following Product Segments: Bare Metal ... Corporation, Medtronic, Inc., Medtronic Cardiovascular, Inc., OrbusNeich, and Terumo Europe N.V. Market data and analytics are derived from primary and secondary ...
October 2011
396 pages
Ambulatory and Bathroom Aids: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Ambulatory and Bathroom Aids in US$ Million and Thousand Units by the following Product Segments: ... Ltd., Rebotec Rehabilitationsmittel GmbH, Sunrise Medical, and Thomas Fetterman, Inc. Market data and analytics are derived from primary and secondary research. ...
October 2011
654 pages
Blood Glucose Meters And Strips: Market Research Report
US$ 4,500.00
... for Blood Glucose Meters and Strips in US$ Million by the following Product Segments: Blood Glucose Strips, and Blood Glucose Meters. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. ...
October 2011
446 pages
CIPLA, Para IV Upside To Continue: Its Lexapro After Zyprexa
US$ 350.00
... of $1b) under 180-day exclusivity starting 14 March 2012. Cipla remained an active partner to Ivax (now Teva) by developing ... -day exclusivity. Thus Cipla too will share the upsides from the exclusivity. We expect Cipla to gain $50m ... will start accruing immediately after the upside from Zyprexa API supply to Teva ...
October 2011
3 pages
Assessment of the Asian Medical Tourism Industry
US$ 800.00
... the developed countries. Apart from the US and Europe, the demand for private healthcare in Asia constitutes of patients from Africa and the Middle East, where the healthcare infrastructure is still under-developed. Why should the report be purchased? Our report ‘Assessment of the Asian Medical ...
October 2011
25 pages
DAIICHI SANKYO - Edoxaban Gets Edge as Key Japanese Factor-Xa Inhibitors Fall!
US$ 140.00
Recent failures of Edoxaban’s key competitor factor-Xa inhibitors from Japan - YM 150 (Astellas) and TAK-442 (Takeda), the closest candidate in Japan now is Xarelto ... years away from hitting the market. Edoxaban is the first and only approved factor-Xa inhibitor in Japan for prevention of VTE, though Japanese ...
September 2011
4 pages
ROCHE, GLAXOSMITHKLINE - Exciting Data on TDM1 - Will Keep Competition at Bay
US$ 140.00
... months compared to Herceptin + docetaxel (14.2 m vs. 9.2 m- Table 1). The safety data as well, is very convincing as T-DM1 cut Grade 3 or more adverse effects ... 50% (46.4% vs. 89.4%). With T-DM1 and pertuzumab arrows in its quiver, Roche is well poised to sustain its breast cancer franchise beyond Herceptin ...
September 2011
4 pages
Observing Patients Online: the changing face of research
US$ 595.00
For years, patients have shouted to be heard. But as online patient communities, chat rooms and forums have gained popularity—and political clout—their voices are resonating.
Now being used t...
September 2011
47 pages
The 2011 Global Orthopedics Market Dynamics and Trends
US$ 1,480.00
... categories. In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major ...
September 2011
53 pages
Ear Care in Turkey
US$ 990.00
... OTC products to be sold in supermarkets and drugstore chains. Euromonitor International's Ear Care in Turkey report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Ear Care market; Pinpoint growth sectors and identify factors driving change ...
September 2011
22 pages
Medicated Skin Care in Tunisia
US$ 990.00
... as anti-bacterial, lightening and sun protection products. Euromonitor International's Medicated Skin Care in Tunisia report offers a comprehensive guide to the size and shape of the ... and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy ...
September 2011
19 pages
Medicated Skin Care in South Korea
US$ 990.00
... to female consumers in particular. As this issue becomes more... Euromonitor International's Medicated Skin Care in South Korea report offers a comprehensive guide to the size and shape of the ... and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy ...
September 2011
29 pages
The European Orthopedics Market: Strategic Assessments of Leading Suppliers
US$ 7,600.00
The report provides strategic overview of the European orthopedics market, including forecasts for major market segments and product categories. In addition, ... of the major trends with potentially significant impact on the European orthopedics market during the next five years, including industry consolidation ...
September 2011
620 pages
The US Orthopedics Market: Strategic Assessments of Leading Suppliers
US$ 7,600.00
The report provides a strategic overview of the US orthopedics market, including forecasts for major market segments and product categories. In addition, the report presents a concise review of the major trends with potentially significant impact on the US ...
September 2011
620 pages
Vertex - Near Term Positive Long Term Neutral
US$ 140.00
... therapy area is heating up, Vertex (VRTX) will continue to have the edge for at least 3yrs. We expect most of the near term milestones related for ... read our report released on 23th September, 2011 on VRTX titled “Near Term Positive Long Term Neutral”.
September 2011
5 pages
Competitor Analysis: Novel Mitotic Kinase Inhibitors
US$ 550.00
... cell cycle, whereas CDK7 has dual roles as a CDK-activating kinase (CAK) and a regulator of the transcriptional machinery. CDK8 and CDK9 ... Inhibitors Corporate Novel Mitotic Kinase Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, ...
September 2011
62 pages
Competitor Analysis: Her2 and Her3 Receptor Antagonists
US$ 413.00
... active projects in research and development of molecules targeting the Her2 (ErbB2) and Her3 receptor. In addition, the report lists company-specific ... Antagonists Pan-Her Receptor Antagonists Corporate Her2 and Her3 Receptor Antagonist R&D Pipelines About La Merie About Competitor Analysis Series: The ...
September 2011
63 pages
Competitor Analysis: EGF-R Agonists and Antagonists
US$ 533.00
... -R and Her2 Receptor Antagonists Pan-ErbB (pan-Her) Receptor Antagonists Multi-Target EGF-R Antagonists Others Corporate EGF-R Agonist and Antagonist R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about ...
September 2011
73 pages
Therapeutic Apheresis: Market Research Report
US$ 4,500.00
This report analyzes the US market for Therapeutic Apheresis in US$ Thousand by the following procedures: Photopheresis, Plasmapheresis, Erythrocytapheresis, Plateletpheresis, Leukapheresis, and Lipidpheresis. The specific end-use segments analyzed are Neurology Disorders, Hematology & Oncology Disorders, ...
September 2011
126 pages
Apoptosis: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Apoptosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia ... Pte Ltd., S*BIO Pte Ltd, TopoTarget A/S, Xigen SA, and ?terna Zentaris GmbH. Market data and analytics are derived from primary and secondary research ...
September 2011
617 pages
Enteral Feeding Pumps: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Enteral Feeding Pumps in US$ Million. The report provides separate comprehensive analytics for the US ... AG, Moog Inc., Nestle HealthCare Nutrition, and Nutricia Advanced Medical Nutrition. Market data and analytics are derived from primary and secondary research. ...
September 2011
190 pages
